Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects
|ClinicalTrials.gov Identifier: NCT00885729|
Recruitment Status : Active, not recruiting
First Posted : April 22, 2009
Last Update Posted : October 15, 2015
University Hospital, Akershus
Information provided by (Responsible Party):
Asbjorn Aroen, University Hospital, Akershus
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Active, not recruiting|
|Actual Primary Completion Date :||July 2011|
|Estimated Study Completion Date :||July 2018|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Årøen A, Brøgger H, Røtterud JH, Sivertsen EA, Engebretsen L, Risberg MA. Evaluation of focal cartilage lesions of the knee using MRI T2 mapping and delayed Gadolinium Enhanced MRI of Cartilage (dGEMRIC). BMC Musculoskelet Disord. 2016 Feb 11;17:73. doi: 10.1186/s12891-016-0941-y.
Røtterud JH, Reinholt FP, Beckstrøm KJ, Risberg MA, Arøen A. Relationship between CTX-II and patient characteristics, patient-reported outcome, muscle strength, and rehabilitation in patients with a focal cartilage lesion of the knee: a prospective exploratory cohort study of 48 patients. BMC Musculoskelet Disord. 2014 Mar 24;15:99. doi: 10.1186/1471-2474-15-99.
Wondrasch B, Arøen A, Røtterud JH, Høysveen T, Bølstad K, Risberg MA. The feasibility of a 3-month active rehabilitation program for patients with knee full-thickness articular cartilage lesions: the Oslo Cartilage Active Rehabilitation and Education Study. J Orthop Sports Phys Ther. 2013 May;43(5):310-24. doi: 10.2519/jospt.2013.4354. Epub 2013 Mar 13.